Deutsche Bank’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-622,226
| Closed | -$62.2K | – | 3621 |
|
|
2025
Q4 | $62.2K | Hold |
622,226
| – | – | ﹤0.01% | 3416 |
|
|
2025
Q3 | $380K | Sell |
622,226
-1
| -0% | – | ﹤0.01% | 2694 |
|
|
2025
Q2 | $193K | Sell |
622,227
-3,844,358
| -86% | -$1.49M | ﹤0.01% | 2991 |
|
|
2025
Q1 | $2.19M | Sell |
4,466,585
-1,537
| -0% | -$905 | ﹤0.01% | 1687 |
|
|
2024
Q4 | $3.84M | Buy |
4,468,122
+30,520
| +0.7% | +$191K | ﹤0.01% | 1466 |
|
|
2024
Q3 | $37.7M | Buy |
4,437,602
+2,094,119
| +89% | +$12.3M | 0.02% | 675 |
|
|
2024
Q2 | $10.9M | Buy |
2,343,483
+1,721,256
| +277% | +$8.15M | ﹤0.01% | 980 |
|
|
2024
Q1 | $4.23M | Buy |
+622,227
| New | +$2.79M | ﹤0.01% | 1338 |
|
|
2022
Q2 | – | Sell |
-31,910
| Closed | -$67K | – | 4125 |
|
|
2022
Q1 | $67K | Buy |
31,910
+20,505
| +180% | +$54.9K | ﹤0.01% | 3733 |
|
|
2021
Q4 | $102K | Sell |
11,405
-12,230
| -52% | -$161K | ﹤0.01% | 3692 |
|
|
2021
Q3 | $392K | Buy |
23,635
+12,475
| +112% | +$215K | ﹤0.01% | 3190 |
|
|
2021
Q2 | $232K | Buy |
11,160
+763
| +7% | +$14.4K | ﹤0.01% | 3699 |
|
|
2021
Q1 | $195K | Buy |
10,397
+194
| +2% | +$4.18K | ﹤0.01% | 3642 |
|
|
2020
Q4 | $224K | Buy |
10,203
+2,346
| +30% | +$48.8K | ﹤0.01% | 3406 |
|
|
2020
Q3 | $163K | Buy |
7,857
+186
| +2% | +$4.84K | ﹤0.01% | 3321 |
|
|
2020
Q2 | $277K | Buy |
7,671
+4,831
| +170% | +$202K | ﹤0.01% | 2958 |
|
|
2020
Q1 | $93K | Buy |
2,840
+474
| +20% | +$19.2K | ﹤0.01% | 3282 |
|
|
2019
Q4 | $64K | Buy |
2,366
+1,832
| +343% | +$31.4K | ﹤0.01% | 3833 |
|
|
2019
Q3 | $5K | Buy |
+534
| New | +$5.04K | ﹤0.01% | 4643 |
|
Deutsche Bank's APLT Position: Q1 2026 in Review
Deutsche Bank sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 622,226 shares — an estimated $62.2K sold.
Deutsche Bank first reported a position in APLT in Q3 2019 and held it in 19 quarters. The position peaked at $37.7M in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Deutsche Bank reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Deutsche Bank sold 622,226 Applied Therapeutics shares in Q1 2026, an estimated $62.2K.
- Deutsche Bank first reported a position in Applied Therapeutics in Q3 2019 and held it in 19 quarters.
- Deutsche Bank's Applied Therapeutics position peaked at $37.7M in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.